RENOVARO INC. - COMMON STOCK

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

22 Apr 2025 09:19:59 By Nasdaq GlobeNewswire

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

09 Apr 2025 09:25:00 By Nasdaq GlobeNewswire

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

04 Apr 2025 09:40:00 By Nasdaq GlobeNewswire

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

03 Mar 2025 09:15:00 By Nasdaq GlobeNewswire

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

26 Feb 2025 13:25:00 By Nasdaq GlobeNewswire

Renovaro Announces $15 million in Equity Committed

26 Feb 2025 09:15:00 By Nasdaq GlobeNewswire

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

07 Jan 2025 09:15:00 By Nasdaq GlobeNewswire

Renovaro Issues Shareholder Letter and Provides Corporate Update

07 Jan 2025 09:15:00 By Nasdaq GlobeNewswire

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

06 Jan 2025 09:15:00 By Nasdaq GlobeNewswire

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

30 Dec 2024 09:00:05 By Nasdaq GlobeNewswire

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

23 Dec 2024 09:00:00 By Nasdaq GlobeNewswire

Renovaro Regains Compliance with NASDAQ Listing Requirement

20 Dec 2024 15:40:00 By Nasdaq GlobeNewswire

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

20 Dec 2024 09:00:00 By Nasdaq GlobeNewswire

Renovaro Issues Shareholder Letter and Provides Corporate Update

04 Nov 2024 08:31:00 By Nasdaq GlobeNewswire

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

17 Oct 2024 09:15:17 By Nasdaq GlobeNewswire

Renovaro Announces Strategic Restructuring and Leadership Transition

16 Oct 2024 09:28:06 By Nasdaq GlobeNewswire

PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics

19 Sep 2024 09:00:00 By Nasdaq GlobeNewswire

Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

17 Sep 2024 09:00:00 By Nasdaq GlobeNewswire

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

13 Sep 2024 09:00:00 By Nasdaq GlobeNewswire

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

11 Sep 2024 09:15:00 By Nasdaq GlobeNewswire